Satoru Saito - Concepedia

Author

Satoru Saito

Also Known As

S SAITO, S Saito, S. SAITO, S. Saito, Satoru SAITO, Satoru Saito, Satoru Saito (94255), Shuna Saito, Syuna Saito, Tohru Kotani

357

Publications

10.3K

Citations

H-Index

149

Concepts

All Affiliations

Yokohama City University Yokohama City University Hospital The University of Osaka Kitakashiwa Rehabilitation General Hospital International University of Health and Welfare

About

Satoru Saito is an author at Yokohama City University specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	52	3.2K
2	Health Sciences	13	15	1.5K
3	Natural Sciences	2	2	135
4	Public Health	1	1	16
5	Anesthesia	1	1	25

Satoru Saito

157

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography Kento Imajo, Takaomi Kessoku, Yasushi Honda, Gastroenterology	2015	784
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD) Masato Yoneda, Masato Yoneda, Hironori Mawatari, Digestive and Liver Disease Liver FibrosisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseLiver Physiology	2007	421
Nonalcoholic Fatty Liver Disease: US-based Acoustic Radiation Force Impulse Elastography Masato Yoneda, Kaori Suzuki, Shingo Kato, Radiology	2010	347
Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling Kento Imajo, Koji Fujita, Masato Yoneda, Cell Metabolism InflammationHepatologyLow-dose EndotoxinLiver PhysiologyPhysiology	2012	334
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH Masato Yoneda, Hironori Mawatari, Koji Fujita, Journal of Gastroenterology Liver FibrosisImmunologyPathologyFatty Liver DiseaseCirrhosis	2007	291
Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis # † Koji Fujita, Yuichi Nozaki, Koichiro Wada, Hepatology	2009	238
Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition Toshio Fujisawa, Hideki Endo, Ayako Tomimoto, Gut	2008	182
The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice Yasushi Honda, Kento Imajo, Takayuki Kato, PLoS ONE	2016	166
Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis Kensuke Kubota, Hiroshi Iida, Toshio Fujisawa, Gastrointestinal Endoscopy Autoimmune DiseaseClinical FactorsImmunologyGastroenterologyPathology	2007	138
Efficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: An open‐label, pilot study Masato Yoneda, Koji Fujita, Yuichi Nozaki, Hepatology Research	2010	138

Page 1